Unique clinical trials and novel products of interest currently under investigation for the treatment of dry eye disease.
Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.
Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Staying current on phaco technology can help surgeons provide better outcomes.
Advancements in imaging make ICL an effective option for a wider range of patients.
There have been 8 reported patients with vision loss as well as 4 reports of enucleation, or surgical removal of eyeball.
There’s no shortage of diet programs—Paleo, Mediterranean, intermittent fasting—all claiming to be the best option for a healthy life. Research has shown that poor lifestyle choices, including unhealthy diets, contribute to many diseases and that simply adhering to good nutrition can even prevent some health issues.
Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.
Knowledge of tools used in data interpretation helps clinicians trust accuracy of findings.
Papilledema with back pain suggests spine lesion.
Solutions should address staffing shortages and burnout.
The FEMCAT study found that FLACS is not superior to conventional approach
Results concluded that K did better than TK in a variety of situations.
Despite current flexibility, future enforcement could prove to be troublesome
Despite its promise, RGC replacement represents a more formidable challenge.
Bi-sign design compensates for aberrations resulting from misalignment.
Growing patient pool is driving clinical trial investment.
Multiple attendees of this year's EnVision Summit share insights into what makes the EnVision Summit an enjoyable experience and a great place to learn.
To control pain and inflammation most effectively and responsibly for our cataract surgery patients, we must not only use the appropriate drugs but also ensure they are delivered in the most beneficial manner. We should be mindful of the implications of our pharmaceutical strategies and their impact on our patients.
Case of anterior segment ischemia involves young adult with prior carotid artery injury.
Carolyn Majcher, OD, FAAO, and Rishi Singh, MD, discuss new and upcoming clinical trials, investigational therapies, and diagnostic tools for the treatment of diabetic retinopathy and diabetic macular edema (DR/DME).
Over the years, IKA has become an invaluable resource for eye care professionals.
Ehsan Sadri, MD FACS, A minimally invasive glaucoma surgery specialist discusses impressions and key take away points from patient case.
Evidence-based medicine can lead to personalized care, better results for patients
Technical details, communication style key to presbyopia-correcting IOL journey.
Considerations in the treatment of diabetic retinopathy and diabetic macular edema.
Grazia Pertile, MD, discusses the highlights of her presentations on the management of retinal folds after retinal detachment and the role of the anterior vitreous as a cause of recurrent retinal detachment.